X
GSK buys Avalon-partnered Sitari and its coeliac drug
https://pharmaphorum.com/news/gsk-buys-avalon-partnered-sitari-and-its-coeliac-drug/
autoimmune disease
Genentech’s Rituxan approved for rare skin disease
The FDA has approved Genentech’s Rituxan (rituximab) for use in adults with moderate-to-severe pemphigus vulgaris (PV), making it the first treatment for the condition in more than 60 years.